Key Metrics
16.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
10 - 15
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
130
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.95
5-Year SI
5-year SI
- 0.91 2-year SI
- 0.93 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Molecular Medicine
SJR
- Q1 Molecular Medicine
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
2.15
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Breast cancer
- Carcinogenesis
- Parkinson's disease
- Extracellular matrix
- Sepsis
- Autophagy
- Bone formation
- Lactate dehydrogenase
- Jeune syndrome
- Myeloid cells
- Human tumor
- DNA damage
- Gliosis
- Glioblastoma
- Dual targeting
- Cerebrospinal fluid
- Heart failure
- Colorectal cancer
- Negative regulator
- Cerebrovascular pathology
Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | USD 5000 | GBP 3960 | EUR 4500 |
| Publication Time | 26 |
| Editorial Review Process | Anonymous peer review,Double anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | EMBO |
| Frequency | Monthly |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 26 |
| Article Processing Charges | USD 5000 | GBP 3960 | EUR 4500 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review,Double anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
Planning to publish in EMBO Molecular Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Beneficial microbiome and diet interplay in early-onset colorectal cancer.
- 9 Dec 24
- EMBO molecular medicine
-
Full paper
A novel anti-epileptogenesis strategy of temporal lobe epilepsy based on nitric oxide donor.
- 9 Dec 24
- EMBO molecular medicine
-
Full paper
Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome.
- 9 Dec 24
- EMBO molecular medicine
-
Full paper
The inflammasome adaptor protein ASC promotes amyloid deposition in cryopyrin-associated periodic syndromes.
- 5 Dec 24
- EMBO molecular medicine
-
Full paper
BMP-9 mediates fibroproliferation in fibrodysplasia ossificans progressiva through TGF-β signaling.
- 3 Dec 24
- EMBO molecular medicine
-
Full paper
Targeting to BMP9 to restrain flare-up of fibrodysplasia ossificans progressiva.
- 3 Dec 24
- EMBO molecular medicine
Scite analysis
Powered by scite_
1.9k articles received 117.7k citations see all
- 5,214 Supporting
- 110,995 Mentioning
- 374 Contrasting
Editorial notices
- 1 Retractions
- 0 Withdrawals
- 37 Corrections
- 29 Errata
- 0 Expression of Concern
FAQs
How long has EMBO Molecular Medicine been actively publishing?
EMBO Molecular Medicine has been in operation since 2009 till date.
What is the publishing frequency of EMBO Molecular Medicine ?
EMBO Molecular Medicine published with a Monthly frequency.
How many articles did EMBO Molecular Medicine publish last years ?
In 2023, EMBO Molecular Medicine published 148 articles.
What is the eISSN & pISSN for EMBO Molecular Medicine ?
For EMBO Molecular Medicine,eISSN is 1757-4684 and pISSN is1757-4676.
What is Citescore for EMBO Molecular Medicine ?
Citescore for EMBO Molecular Medicine is 16.2.
What is H index for EMBO Molecular Medicine ?
H index for EMBO Molecular Medicine is 130.
What is SNIP score for EMBO Molecular Medicine ?
SNIP score for EMBO Molecular Medicine is 2.15.
What is the SJR for EMBO Molecular Medicine ?
SJR for EMBO Molecular Medicine is Q1.
Who is the publisher of EMBO Molecular Medicine ?
WILEY is the publisher of EMBO Molecular Medicine.